The Case of the Elusive Androgen

    November 2002 in “ Endocrine practice
    Rhoda H. Cobin
    Image of study
    TLDR The patient's high testosterone was reduced by a medication that suppresses gonadotropin.
    In 2002, a case report detailed a 62-year-old post-menopausal woman with severe hirsutism and scalp alopecia, unresponsive to spironolactone treatment, who had an abnormally high testosterone level of 644 ng/dL. Initial surgery, including a total abdominal hysterectomy and bilateral oophorectomy, revealed bilateral hilar cell hyperplasia in the ovaries, but did not normalize testosterone levels. Further investigation identified and removed a 9-mm adenoma in the left adrenal gland, yet testosterone levels remained high. Subsequent tests ruled out adrenal gland pathology. Ultimately, treatment with nafarelin, a gonadotropin-suppressing agent, significantly reduced testosterone levels and improved clinical symptoms. The study concluded that the patient likely had residual testosterone-producing tissue, sensitive to gonadotropins, from primitive mesenchymal cells in an unidentified location in the abdomen or pelvis.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

    Related Research

    5 / 5 results